Indaptus Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Indaptus Therapeutics

14/08/2023 14:02

* Indaptus Therapeutics Inc  INDP.OQ  reported a quarterly
adjusted loss of 39 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 58 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Indaptus Therapeutics Inc's reported EPS for the quarter
was a
loss of 39 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Indaptus Therapeutics Inc shares had risen by 20.4% this
quarter and gained 58.6% so far this year.
    * The company reported a quarterly loss of $3.25 million.
    * Wall Street's median 12-month price target for Indaptus
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.58          -0.39          Beat
 Mar. 31 2023      -0.59          -0.51          Beat
 Dec. 31 2022      -0.52          -0.44          Beat
 Sep. 30 2022      -0.53          -0.42          Beat